AVILECT

Welcome to the Brand page for “AVILECT”, which is offered here for Pharmaceutical and biologic preparations for immunological disorders, diseases, and conditions; pharmaceutical and biologic preparations for the treatment of degenerative and inflammatory diseases and disorders, immune evasion, and immune dysfunction; pharmaceutical and biologics preparations for use in ophthalmology, oncology, neurology, immunology, and fibrosis; therapeutic agents in the nature of glycol-ligand nanoparticles and antibodies for modulating inflammation and other immune activities; immunotherapies and glycol-therapeutics;medical scientific testing for research purposes and research and development services in the fields of glycome, glycol-therapeutics, diseases and disorders involving the immune system, pharmaceuticals, and biologics; providing medical scientific information in the fields of glycome, glycol-therapeutics diseases and disorders involving the immune system, pharmaceuticals, and biologics;.

Its status is currently believed to be active. Its class is unavailable. “AVILECT” is believed to be currently owned by “Avilect Biosciences, Inc.”